Heather Grieve, Martin Hawes, Catherine Hemingway, Elizabeth Wright, David Killick
{"title":"Teaching Student Veterinary Professionals About Pharmacovigilance: A Survey of UK Veterinary Educators.","authors":"Heather Grieve, Martin Hawes, Catherine Hemingway, Elizabeth Wright, David Killick","doi":"10.1111/jvp.70054","DOIUrl":null,"url":null,"abstract":"<p><p>Adverse drug event (ADE) reports submitted by veterinary professionals are essential for monitoring the safety and efficacy of marketed veterinary products. Despite this, the majority of veterinary ADEs are not reported. Further education on the topic of pharmacovigilance has been widely explored in human healthcare as a potential facilitator for reporting. To guide design of an enhanced pharmacovigilance curriculum for veterinary professionals, a better understanding of student veterinary professional pharmacovigilance training is required. Therefore, we investigated the current UK pharmacovigilance curriculum through a survey of veterinary educators. In total, there were 17 responses from UK-based training providers, six relating to undergraduate veterinary surgeon training and 11 relating to training in veterinary nursing. All students received some pharmacovigilance training, which appeared to be largely didactic in nature. A total of 29.4% of respondents indicated that students are provided the opportunity to submit a practice ADE report. Exploration of the knowledge, attitudes, and perceptions of students with regards to this training would be useful in assessing quality and opportunities for enhancement. Development of shared resources which provide students with access to 'real world' examples of ADEs would support development of practical skills in identifying, managing, and reporting ADEs.</p>","PeriodicalId":17596,"journal":{"name":"Journal of veterinary pharmacology and therapeutics","volume":" ","pages":""},"PeriodicalIF":1.4000,"publicationDate":"2026-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of veterinary pharmacology and therapeutics","FirstCategoryId":"97","ListUrlMain":"https://doi.org/10.1111/jvp.70054","RegionNum":4,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Adverse drug event (ADE) reports submitted by veterinary professionals are essential for monitoring the safety and efficacy of marketed veterinary products. Despite this, the majority of veterinary ADEs are not reported. Further education on the topic of pharmacovigilance has been widely explored in human healthcare as a potential facilitator for reporting. To guide design of an enhanced pharmacovigilance curriculum for veterinary professionals, a better understanding of student veterinary professional pharmacovigilance training is required. Therefore, we investigated the current UK pharmacovigilance curriculum through a survey of veterinary educators. In total, there were 17 responses from UK-based training providers, six relating to undergraduate veterinary surgeon training and 11 relating to training in veterinary nursing. All students received some pharmacovigilance training, which appeared to be largely didactic in nature. A total of 29.4% of respondents indicated that students are provided the opportunity to submit a practice ADE report. Exploration of the knowledge, attitudes, and perceptions of students with regards to this training would be useful in assessing quality and opportunities for enhancement. Development of shared resources which provide students with access to 'real world' examples of ADEs would support development of practical skills in identifying, managing, and reporting ADEs.
期刊介绍:
The Journal of Veterinary Pharmacology and Therapeutics (JVPT) is an international journal devoted to the publication of scientific papers in the basic and clinical aspects of veterinary pharmacology and toxicology, whether the study is in vitro, in vivo, ex vivo or in silico. The Journal is a forum for recent scientific information and developments in the discipline of veterinary pharmacology, including toxicology and therapeutics. Studies that are entirely in vitro will not be considered within the scope of JVPT unless the study has direct relevance to the use of the drug (including toxicants and feed additives) in veterinary species, or that it can be clearly demonstrated that a similar outcome would be expected in vivo. These studies should consider approved or widely used veterinary drugs and/or drugs with broad applicability to veterinary species.